,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Cognitive disorder,6,15802757
1,22.0,Herpes zoster,6,15802757
2,22.0,Gingival pain,6,15802757
3,22.0,Chills,6,15802757
4,22.0,Dysstasia,6,15802757
5,22.0,Pathological fracture,6,15802757
6,22.0,Insomnia,6,15802757
7,22.0,Fatigue,6,15802757
8,22.0,Paraesthesia,6,15802757
9,22.0,Visual impairment,6,15802757
10,22.0,Tetany,6,15802757
11,22.0,Disturbance in attention,6,15802757
12,22.0,Neuralgia,6,15802757
13,22.0,Mucosal toxicity,6,15802757
14,22.0,Skin sensitisation,6,15802757
15,22.0,Tooth disorder,6,15802757
16,22.0,Arthralgia,6,15802757
17,22.0,Gait disturbance,6,15802757
18,22.0,Visual acuity reduced,6,15802757
19,22.0,Facial pain,6,15802757
20,22.0,Platelet count decreased,6,15802757
21,22.0,Vulvovaginal dryness,6,15802757
22,22.0,Hepatocellular injury,2,15802757
23,22.0,Dizziness,6,15802757
24,22.0,Muscle contracture,6,15802757
25,22.0,Emotional disorder,6,15802757
26,22.0,Depressive symptom,6,15802757
27,22.0,Ageusia,6,15802757
28,22.0,Pain in extremity,6,15802757
29,22.0,Hot flush,6,15802757
30,22.0,Nausea,6,15802757
31,22.0,Muscle spasms,6,15802757
32,22.0,Tinnitus,6,15802757
33,22.0,Periostitis,6,15802757
34,22.0,Menorrhagia,6,15802757
35,22.0,Pain,6,15802757
36,22.0,Neuropathy peripheral,6,15802757
37,22.0,Weight increased,2,15802757
38,22.0,Skin toxicity,6,15802757
39,22.0,Disturbance in attention,6,15802757
40,22.0,Vomiting,6,15802757
41,22.0,Hallucination,6,15802757
42,22.0,Sensory loss,6,15802757
43,22.0,Loss of libido,6,15802757
0,22.0,Axonal neuropathy,2,15802770
0,21.1,Disease progression,,15802787
0,22.0,Anaemia,1,15802801
0,21.1,Intestinal obstruction,1,15802810
1,21.1,Product use in unapproved indication,6,15802810
0,21.1,Fatigue,3,15802811
1,21.1,Malignant neoplasm progression,6,15802811
2,21.1,Wound complication,3,15802811
3,21.1,Breast cancer,6,15802811
4,21.1,Breast mass,6,15802811
5,21.1,Hypotension,3,15802811
6,21.1,Wound secretion,2,15802811
7,21.1,Wound,2,15802811
0,22.0,Diabetic ketosis,1,15802813
0,22.0,Pyrexia,6,15802856
1,22.0,Lymphopenia,6,15802856
2,22.0,Hyponatraemia,6,15802856
3,22.0,Febrile neutropenia,6,15802856
4,22.0,Confusional state,6,15802856
5,22.0,Thrombocytopenia,6,15802856
6,22.0,Dyspnoea,6,15802856
7,22.0,Hypophosphataemia,6,15802856
8,22.0,Anaemia,6,15802856
0,22.1,Hyponatraemia,1,15802871
1,22.1,Flushing,1,15802871
2,22.1,Polydipsia,1,15802871
0,21.1,Acute leukaemia,5,15802890
1,21.1,Death,5,15802890
2,21.1,Second primary malignancy,5,15802890
0,22.1,Hypoacusis,6,15802928
1,22.1,White blood cell count decreased,1,15802928
0,21.1,Gastrointestinal erosion,6,15802992
1,21.1,Weight decreased,6,15802992
2,21.1,Vomiting,6,15802992
3,21.1,Blood pressure increased,6,15802992
4,21.1,Fatigue,3,15802992
5,21.1,Nausea,6,15802992
6,21.1,Diarrhoea,3,15802992
0,21.1,Hospice care,,15803054
0,21.1,Death,5,15803068
0,22.0,Pneumonitis,6,15803087
0,21.1,Bone marrow failure,3,15803090
1,21.1,White blood cell count decreased,1,15803090
2,21.1,Platelet count decreased,3,15803090
0,21.1,Cardiac disorder,6,15803109
0,22.0,Death,5,15803111
0,22.1,Oropharyngeal blistering,1,15803132
1,22.1,Malaise,1,15803132
2,22.1,Tongue blistering,1,15803132
3,22.1,Oral mucosal blistering,1,15803132
4,22.1,Candida infection,1,15803132
5,22.1,Respiratory tract congestion,1,15803132
0,21.1,Ascites,6,15803156
1,21.1,Neoplasm progression,6,15803156
0,21.1,Pneumonia,2,15803204
0,21.1,Enterocolitis haemorrhagic,6,15803219
0,21.1,Mania,2,15803235
0,21.1,Myocardial infarction,6,15803270
1,21.1,Pulmonary oedema,6,15803270
2,21.1,Medical device pain,6,15803270
3,21.1,Body height decreased,3,15803270
4,21.1,Drug ineffective,3,15803270
5,21.1,Fluid retention,6,15803270
6,21.1,Chest discomfort,1,15803270
7,21.1,Cardiac failure,3,15803270
8,21.1,Cardiac disorder,3,15803270
9,21.1,Pleural effusion,6,15803270
10,21.1,Weight decreased,3,15803270
0,21.1,Loss of consciousness,2,15803288
1,21.1,Speech disorder,6,15803288
2,21.1,Weight decreased,6,15803288
3,21.1,Metastases to central nervous system,2,15803288
4,21.1,Gait disturbance,6,15803288
5,21.1,Facial paresis,2,15803288
6,21.1,Thrombocytopenia,1,15803288
7,21.1,Nausea,6,15803288
8,21.1,Epilepsy,2,15803288
9,21.1,Malignant neoplasm progression,2,15803288
0,21.1,Blood test abnormal,6,15803313
0,21.1,Thrombocytopenia,6,15803331
1,21.1,Anaemia,6,15803331
0,22.0,Fatigue,6,15803339
1,22.0,Abdominal distension,6,15803339
2,22.0,Haematochezia,6,15803339
3,22.0,Epistaxis,6,15803339
4,22.0,Anaemia,6,15803339
5,22.0,Condition aggravated,6,15803339
6,22.0,Pneumonia,2,15803339
7,22.0,Dyspepsia,6,15803339
8,22.0,Flatulence,6,15803339
9,22.0,Neuropathy peripheral,2,15803339
10,22.0,Rectal haemorrhage,6,15803339
11,22.0,Gastrointestinal haemorrhage,6,15803339
12,22.0,Skin disorder,2,15803339
13,22.0,Musculoskeletal chest pain,6,15803339
0,21.1,Peripheral swelling,,15803460
0,21.1,Erythema,1,15803472
1,21.1,Product use in unapproved indication,6,15803472
2,21.1,Off label use,6,15803472
3,21.1,Bacteraemia,1,15803472
0,21.1,Diarrhoea,2,15803475
1,21.1,Pain,2,15803475
2,21.1,Blood alkaline phosphatase decreased,2,15803475
3,21.1,Metastases to spine,,15803475
4,21.1,Metastases to bone,,15803475
0,21.1,Pre-existing condition improved,,15803476
1,21.1,Condition aggravated,,15803476
2,21.1,Metastases to bone,,15803476
3,21.1,Metastases to pelvis,,15803476
4,21.1,Metastases to bone,,15803476
5,21.1,Metastases to spine,,15803476
6,21.1,Pain,2,15803476
7,21.1,Anaemia,,15803476
0,21.1,Lung infection,1,15803487
1,21.1,Cerebrovascular accident,1,15803487
0,21.1,Platelet count decreased,3,15803488
1,21.1,Electrocardiogram QT prolonged,1,15803488
2,21.1,Deep vein thrombosis,1,15803488
0,21.1,Pneumothorax,1,15803490
0,21.1,Diarrhoea,,15803501
1,21.1,Nausea,,15803501
2,21.1,Thrombocytopenia,,15803501
3,21.1,Anaemia,,15803501
4,21.1,Metastasis,,15803501
0,21.1,Therapy change,,15803577
1,21.1,Malignant neoplasm progression,,15803577
0,21.1,Vomiting,,15803663
1,21.1,Rash,,15803663
0,21.1,Oedema,6,15803725
1,21.1,Spinal fracture,6,15803725
2,21.1,Peripheral swelling,6,15803725
3,21.1,Dehydration,6,15803725
0,21.1,Upper gastrointestinal haemorrhage,3,15803739
1,21.1,Pneumonia aspiration,2,15803739
2,21.1,Hepatic function abnormal,3,15803739
0,21.1,Product packaging issue,6,15803740
1,21.1,Product packaging quantity issue,6,15803740
2,21.1,Arthralgia,6,15803740
3,21.1,Nausea,6,15803740
4,21.1,Circumstance or information capable of leading to medication error,6,15803740
5,21.1,Neuropathy peripheral,3,15803740
6,21.1,Product dose omission,6,15803740
0,21.1,Interstitial lung disease,5,15803771
0,21.1,Nausea,1,15803863
1,21.1,Bone pain,1,15803863
2,21.1,Pain,1,15803863
3,21.1,Peripheral sensory neuropathy,2,15803863
4,21.1,Febrile neutropenia,1,15803863
5,21.1,Dyspnoea,1,15803863
6,21.1,Arthralgia,1,15803863
7,21.1,Constipation,2,15803863
8,21.1,Mucosal inflammation,6,15803863
9,21.1,Mucosal inflammation,1,15803863
10,21.1,Mucosal inflammation,1,15803863
11,21.1,Anaemia,2,15803863
12,21.1,Constipation,1,15803863
13,21.1,Hypertension,1,15803863
14,21.1,Stomatitis,1,15803863
15,21.1,Neutropenia,1,15803863
16,21.1,Diarrhoea,4,15803863
17,21.1,Onycholysis,1,15803863
18,21.1,Fatigue,1,15803863
19,21.1,Alopecia,1,15803863
20,21.1,Aspartate aminotransferase increased,1,15803863
21,21.1,Palmar-plantar erythrodysaesthesia syndrome,1,15803863
22,21.1,Rash,1,15803863
23,21.1,Decreased appetite,1,15803863
24,21.1,Neuropathy peripheral,1,15803863
25,21.1,Asthenia,1,15803863
26,21.1,Palmar-plantar erythrodysaesthesia syndrome,1,15803863
27,21.1,Epistaxis,1,15803863
28,21.1,Alanine aminotransferase increased,1,15803863
29,21.1,Cough,1,15803863
30,21.1,Diarrhoea,1,15803863
0,21.1,Pancytopenia,3,15803982
1,21.1,Urticaria,2,15803982
2,21.1,Rash,2,15803982
0,21.1,Nervousness,6,15803987
1,21.1,Weight decreased,6,15803987
2,21.1,Product use in unapproved indication,6,15803987
3,21.1,Off label use,6,15803987
4,21.1,Decreased appetite,6,15803987
5,21.1,Insomnia,6,15803987
6,21.1,Wrong technique in product usage process,6,15803987
7,21.1,Pelvic pain,3,15803987
8,21.1,Urinary tract infection,6,15803987
0,21.1,Cachexia,6,15803999
1,21.1,Abdominal pain,1,15803999
2,21.1,Disease progression,6,15803999
3,21.1,Vomiting,6,15803999
4,21.1,Alopecia,6,15803999
0,21.1,Neutropenia,3,15804034
1,21.1,General physical health deterioration,1,15804034
0,21.1,Dizziness,,15804064
1,21.1,Prostatic specific antigen abnormal,,15804064
2,21.1,Pre-existing condition improved,,15804064
3,21.1,Platelet count decreased,,15804064
4,21.1,Prostate cancer,,15804064
5,21.1,Decreased appetite,,15804064
6,21.1,Mucosal inflammation,,15804064
7,21.1,Asthenia,,15804064
8,21.1,Nausea,,15804064
0,21.1,Hormone-refractory prostate cancer,,15804066
1,21.1,Asthenia,,15804066
2,21.1,Diarrhoea,1,15804066
3,21.1,Decreased appetite,,15804066
4,21.1,Prostatic specific antigen increased,,15804066
5,21.1,Nausea,2,15804066
6,21.1,Abdominal discomfort,,15804066
7,21.1,Abdominal discomfort,,15804066
0,21.1,Metabolic acidosis,1,15804082
1,21.1,Toxicity to various agents,1,15804082
0,21.1,Hypertension,5,15804088
1,21.1,Transaminases increased,6,15804088
2,21.1,Alanine aminotransferase increased,6,15804088
3,21.1,Renal failure,5,15804088
4,21.1,Haemoglobin decreased,6,15804088
5,21.1,Dehydration,5,15804088
6,21.1,Diabetes mellitus,5,15804088
7,21.1,Cardiac failure,5,15804088
8,21.1,Blood phosphorus decreased,6,15804088
9,21.1,Blood calcium decreased,6,15804088
10,21.1,Aspartate aminotransferase increased,6,15804088
11,21.1,Pyrexia,6,15804088
12,21.1,Pneumonia,5,15804088
13,21.1,Diarrhoea,5,15804088
14,21.1,Confusional state,6,15804088
0,21.1,Vaginal cuff dehiscence,1,15804095
0,21.1,Diarrhoea,,15804121
1,21.1,Off label use,,15804121
2,21.1,Dry mouth,3,15804121
3,21.1,Thirst,,15804121
4,21.1,Dry skin,3,15804121
5,21.1,Cystitis,,15804121
6,21.1,Mouth ulceration,3,15804121
7,21.1,Diarrhoea,2,15804121
0,21.1,Asthenia,,15804125
1,21.1,Dyspepsia,,15804125
2,21.1,Prostatic specific antigen increased,3,15804125
3,21.1,Epistaxis,,15804125
4,21.1,Abdominal discomfort,,15804125
5,21.1,Decreased appetite,,15804125
6,21.1,Weight decreased,,15804125
7,21.1,Bone pain,2,15804125
8,21.1,Blood alkaline phosphatase increased,3,15804125
0,21.1,Colorectal cancer,3,15804194
0,21.1,Pyrexia,1,15804213
1,21.1,Hepatic function abnormal,1,15804213
2,21.1,Erythema multiforme,1,15804213
0,21.1,White blood cell count decreased,1,15804214
1,21.1,General physical health deterioration,6,15804214
2,21.1,Haematotoxicity,6,15804214
3,21.1,Platelet count decreased,1,15804214
0,21.1,Deep vein thrombosis,6,15804271
0,21.1,Renal disorder,1,15804272
1,21.1,Dehydration,6,15804272
2,21.1,Vomiting,1,15804272
3,21.1,Nausea,3,15804272
0,21.1,Nausea,6,15804344
0,21.1,Alopecia,6,15804348
0,21.1,Mania,3,15804411
0,21.1,Bronchitis,6,15804453
1,21.1,Diarrhoea,6,15804453
2,21.1,Skin ulcer,6,15804453
3,21.1,Dysgeusia,6,15804453
0,21.1,Off label use,6,15804454
1,21.1,Death,5,15804454
0,21.1,Death,5,15804459
1,21.1,Malignant neoplasm progression,6,15804459
2,21.1,Off label use,6,15804459
0,21.1,Cough,2,15804469
1,21.1,Nausea,2,15804469
2,21.1,Rash,2,15804469
0,21.1,Anaemia,1,15804490
1,21.1,Rash,1,15804490
0,21.1,Nausea,1,15804539
1,21.1,Flushing,1,15804539
2,21.1,Back pain,1,15804539
3,21.1,Retching,1,15804539
4,21.1,Hypoxia,1,15804539
5,21.1,Hyperhidrosis,1,15804539
0,22.0,Urinary tract infection,1,15804541
1,22.0,Hyponatraemia,6,15804541
2,22.0,Leukopenia,6,15804541
3,22.0,Pyrexia,6,15804541
4,22.0,Ageusia,1,15804541
5,22.0,Pancytopenia,1,15804541
6,22.0,Spinal compression fracture,1,15804541
7,22.0,Nausea,1,15804541
0,21.1,Transient ischaemic attack,1,15804545
1,21.1,Pulmonary embolism,2,15804545
0,21.1,Skin laceration,3,15804599
1,21.1,Nail discolouration,1,15804599
2,21.1,Dry skin,3,15804599
3,21.1,Spinal pain,3,15804599
4,21.1,Food aversion,1,15804599
5,21.1,Arthralgia,3,15804599
6,21.1,Dizziness,3,15804599
7,21.1,Oedema,1,15804599
8,21.1,Haematoma,3,15804599
9,21.1,Glossodynia,1,15804599
10,21.1,Visual impairment,3,15804599
11,21.1,Constipation,3,15804599
12,21.1,Injection site erythema,1,15804599
13,21.1,Muscle tightness,1,15804599
14,21.1,Cough,1,15804599
15,21.1,Arthralgia,3,15804599
16,21.1,Arrhythmia,1,15804599
17,21.1,Nail ridging,3,15804599
18,21.1,Dry skin,1,15804599
19,21.1,Gingival bleeding,1,15804599
20,21.1,Injection site pain,1,15804599
0,21.1,Asthenia,6,15804736
1,21.1,Diarrhoea,6,15804736
2,21.1,Decreased appetite,6,15804736
3,21.1,Neutropenic sepsis,2,15804736
4,21.1,Malaise,6,15804736
5,21.1,Gastrointestinal motility disorder,6,15804736
6,21.1,Abdominal pain,6,15804736
0,22.0,Arthritis,3,15804837
0,21.1,Pruritus,1,15804841
1,21.1,Diarrhoea,3,15804841
2,21.1,Polyneuropathy,3,15804841
3,21.1,Epistaxis,3,15804841
4,21.1,Toxic epidermal necrolysis,1,15804841
5,21.1,Muscle spasms,1,15804841
6,21.1,Upper respiratory tract infection,1,15804841
7,21.1,Pyrexia,1,15804841
8,21.1,Sneezing,6,15804841
9,21.1,Nail toxicity,1,15804841
10,21.1,Jugular vein thrombosis,6,15804841
11,21.1,Prescribed underdose,6,15804841
0,21.1,Diarrhoea,1,15804844
1,21.1,Pulmonary embolism,2,15804844
2,21.1,Hypertension,1,15804844
0,22.0,Hordeolum,3,15804902
1,22.0,Flushing,3,15804902
2,22.0,Ear haemorrhage,3,15804902
3,22.0,Skin exfoliation,3,15804902
0,21.1,Pneumothorax,6,15804903
0,21.1,Inappropriate antidiuretic hormone secretion,1,15804907
0,21.1,Bone cancer,3,15804961
1,21.1,Breast cancer recurrent,3,15804961
2,21.1,Malignant neoplasm of pleura,3,15804961
3,21.1,Disease progression,3,15804961
0,21.1,Neutropenia,6,15804982
1,21.1,Bone pain,1,15804982
0,21.1,Mobility decreased,6,15805011
1,21.1,Dysgeusia,6,15805011
2,21.1,Tachycardia,6,15805011
3,21.1,Abdominal discomfort,3,15805011
4,21.1,Fluid intake reduced,6,15805011
5,21.1,Dyspnoea,6,15805011
6,21.1,Cardiovascular disorder,6,15805011
7,21.1,Fatigue,6,15805011
8,21.1,Mucosal inflammation,6,15805011
9,21.1,Nausea,6,15805011
10,21.1,Bone pain,6,15805011
11,21.1,Hypotension,6,15805011
12,21.1,Mental disorder,6,15805011
13,21.1,Weight decreased,6,15805011
14,21.1,Decreased appetite,6,15805011
15,21.1,Asthenia,6,15805011
0,21.1,Back pain,1,15805086
0,21.1,Off label use,6,15805104
1,21.1,Incorrect route of product administration,6,15805104
2,21.1,Product prescribing error,6,15805104
0,21.1,Viral infection,1,15805120
1,21.1,Rash,1,15805120
2,21.1,Angina pectoris,1,15805120
3,21.1,Infarction,6,15805120
4,21.1,Pyrexia,1,15805120
0,21.1,Bradycardia,2,15805121
1,21.1,Hypothyroidism,2,15805121
0,21.1,Flushing,2,15805156
1,21.1,Malaise,2,15805156
0,21.1,Product use in unapproved indication,6,15805171
1,21.1,Death,5,15805171
0,22.0,Pleural effusion,1,15805213
1,22.0,Lung infection,1,15805213
0,21.1,Disease progression,6,15805265
0,21.1,Death,5,15805347
1,21.1,Product use in unapproved indication,6,15805347
0,21.1,Disease progression,6,15805499
0,21.1,Disability,6,15805510
1,21.1,Product packaging quantity issue,6,15805510
0,21.1,Acute kidney injury,5,15805527
1,21.1,Diarrhoea,5,15805527
0,21.1,Skin disorder,2,15805537
1,21.1,Neutropenia,6,15805537
2,21.1,Paronychia,2,15805537
3,21.1,Tumour marker increased,3,15805537
0,22.0,Prostatic specific antigen increased,6,15805554
1,22.0,Back pain,3,15805554
2,22.0,Hypotension,6,15805554
3,22.0,Malignant neoplasm progression,6,15805554
4,22.0,Pain in extremity,3,15805554
0,21.1,Lung carcinoma cell type unspecified recurrent,6,15805599
1,21.1,Metastases to liver,6,15805599
2,21.1,Blood bilirubin decreased,6,15805599
3,21.1,Breast mass,6,15805599
4,21.1,Thrombocytopenia,6,15805599
0,21.1,Death,5,15805625
1,21.1,Product use in unapproved indication,6,15805625
0,21.1,Dementia,6,15805727
1,21.1,Fatigue,6,15805727
2,21.1,Asthenia,6,15805727
0,22.0,Alopecia,2,15805764
1,22.0,Emotional distress,6,15805764
2,22.0,Psychological trauma,6,15805764
0,22.0,Emotional distress,6,15805795
1,22.0,Alopecia,3,15805795
2,22.0,Psychological trauma,6,15805795
0,21.1,Alopecia,2,15805810
0,22.0,Alopecia,2,15805818
0,21.1,Alopecia,3,15805819
1,21.1,Psychological trauma,6,15805819
0,21.1,Breast cancer,5,15805866
0,21.1,Death,5,15805879
0,21.1,Pyrexia,1,15805941
1,21.1,Adenosquamous cell lung cancer,5,15805941
2,21.1,Hepatic function abnormal,3,15805941
0,21.1,Diastolic dysfunction,6,15805942
1,21.1,Systolic dysfunction,6,15805942
0,21.1,Malignant neoplasm progression,5,15805983
0,21.1,Anaemia,6,15806019
0,21.1,Soft tissue infection,5,15806034
0,21.1,Death,5,15806061
1,21.1,Product use in unapproved indication,6,15806061
0,21.1,Death,5,15806074
0,21.1,Death,5,15806083
0,21.1,Ankle fracture,4,15806158
1,21.1,Dizziness,6,15806158
0,21.1,Anaemia,6,15806159
0,21.1,International normalised ratio abnormal,5,15806162
1,21.1,Pseudoxanthoma elasticum,6,15806162
0,21.1,Fatigue,3,15806180
1,21.1,Device dislocation,3,15806180
2,21.1,Procedural pain,,15806180
3,21.1,Stress,3,15806180
4,21.1,Product use in unapproved indication,,15806180
5,21.1,Overweight,3,15806180
6,21.1,Genital haemorrhage,3,15806180
0,21.1,Asthenia,6,15806183
1,21.1,Fatigue,6,15806183
2,21.1,Exercise tolerance decreased,6,15806183
0,22.1,Product prescribing error,6,15806192
1,22.1,Confusional state,6,15806192
2,22.1,Alopecia,1,15806192
0,22.0,Hair disorder,3,15806267
1,22.0,Depression,6,15806267
2,22.0,Mental disorder,6,15806267
3,22.0,Stress,6,15806267
4,22.0,Alopecia,3,15806267
5,22.0,Hair colour changes,3,15806267
6,22.0,Anxiety,6,15806267
7,22.0,Hair texture abnormal,3,15806267
0,21.1,Skin burning sensation,3,15806332
1,21.1,Pruritus,2,15806332
0,21.1,Nausea,6,15806339
1,21.1,Alopecia,6,15806339
0,21.1,Neoplasm progression,3,15806360
0,22.0,Alopecia,6,15806389
1,22.0,Madarosis,6,15806389
2,22.0,Palpitations,6,15806389
3,22.0,White blood cell count decreased,6,15806389
4,22.0,Pain in jaw,1,15806389
5,22.0,Generalised oedema,6,15806389
6,22.0,Arthralgia,6,15806389
7,22.0,Asthenia,6,15806389
8,22.0,Oropharyngeal pain,3,15806389
9,22.0,Pruritus,2,15806389
10,22.0,Nausea,3,15806389
11,22.0,Balance disorder,3,15806389
12,22.0,Weight increased,6,15806389
13,22.0,Pain in extremity,6,15806389
14,22.0,Insomnia,6,15806389
15,22.0,Platelet count decreased,6,15806389
16,22.0,Nervousness,6,15806389
17,22.0,Fatigue,6,15806389
18,22.0,Joint swelling,6,15806389
19,22.0,Red blood cell count decreased,6,15806389
20,22.0,Eye infection,6,15806389
0,21.1,Product use issue,6,15806394
1,21.1,Alopecia,6,15806394
2,21.1,Nausea,6,15806394
0,21.1,Nephrolithiasis,6,15806448
1,21.1,Diarrhoea,3,15806448
2,21.1,Pain,3,15806448
0,21.1,Febrile neutropenia,1,15806475
1,21.1,Leukopenia,1,15806475
0,21.1,Pulmonary embolism,1,15806512
1,21.1,Neutropenia,1,15806512
2,21.1,Diarrhoea,1,15806512
3,21.1,Death,5,15806512
4,21.1,Neutropenia,1,15806512
5,21.1,Febrile neutropenia,1,15806512
6,21.1,Anaemia,1,15806512
7,21.1,Malignant neoplasm progression,5,15806512
8,21.1,Neutropenia,1,15806512
0,21.1,Diarrhoea,3,15806518
1,21.1,Weight decreased,6,15806518
2,21.1,Dyspepsia,6,15806518
3,21.1,Respiration abnormal,6,15806518
4,21.1,Nausea,3,15806518
5,21.1,Red blood cell count decreased,6,15806518
6,21.1,Medication error,6,15806518
7,21.1,Pulmonary embolism,6,15806518
8,21.1,Abdominal rigidity,6,15806518
9,21.1,Carbohydrate antigen 125 increased,6,15806518
10,21.1,Neoplasm progression,3,15806518
11,21.1,Anaemia,6,15806518
12,21.1,Neck pain,6,15806518
13,21.1,Dehydration,6,15806518
14,21.1,Dyspnoea,3,15806518
15,21.1,Dysgeusia,6,15806518
16,21.1,Dizziness,6,15806518
17,21.1,Asthenia,6,15806518
18,21.1,Thirst,3,15806518
19,21.1,Malaise,6,15806518
20,21.1,Insomnia,6,15806518
21,21.1,Nasopharyngitis,6,15806518
22,21.1,Constipation,3,15806518
23,21.1,Blood pressure decreased,6,15806518
24,21.1,Adverse event,6,15806518
25,21.1,Heart rate increased,3,15806518
26,21.1,Fatigue,3,15806518
27,21.1,Haemoglobin decreased,6,15806518
28,21.1,Gastrooesophageal reflux disease,3,15806518
29,21.1,Laboratory test abnormal,6,15806518
30,21.1,Irritable bowel syndrome,6,15806518
31,21.1,Sinusitis,6,15806518
32,21.1,Haematocrit decreased,6,15806518
33,21.1,Abdominal pain upper,6,15806518
0,21.1,Hepatic function abnormal,3,15806547
1,21.1,Malignant neoplasm progression,5,15806547
2,21.1,Pneumothorax,1,15806547
0,22.0,Faeces discoloured,6,15806565
1,22.0,Death,5,15806565
2,22.0,Dyspepsia,6,15806565
3,22.0,Malignant neoplasm progression,3,15806565
4,22.0,Weight decreased,6,15806565
5,22.0,Decreased appetite,6,15806565
0,21.1,Hair disorder,6,15806583
1,21.1,Hair colour changes,6,15806583
2,21.1,Hair texture abnormal,6,15806583
3,21.1,Madarosis,3,15806583
4,21.1,Alopecia,3,15806583
0,21.1,Malignant neoplasm progression,5,15806595
0,21.1,Insomnia,6,15806724
1,21.1,Back pain,1,15806724
0,21.1,Internal haemorrhage,,15806868
0,21.1,Prostatic specific antigen increased,,15807052
0,21.1,Tinnitus,2,15807057
1,21.1,Headache,2,15807057
2,21.1,Physical deconditioning,3,15807057
3,21.1,Ileus,6,15807057
0,21.1,Pain,6,15807098
1,21.1,Thrombosis,6,15807098
0,21.1,Influenza like illness,1,15807164
1,21.1,Upper respiratory tract infection,1,15807164
2,21.1,Urinary tract infection,1,15807164
3,21.1,Gastric ulcer,1,15807164
0,21.1,Chest discomfort,1,15807246
1,21.1,Non-cardiac chest pain,1,15807246
0,21.1,International normalised ratio increased,1,15807247
0,21.1,Hyperthyroidism,1,15807249
0,21.1,Haemolytic anaemia,5,15807253
1,21.1,Clostridium test positive,6,15807253
0,22.0,Neoplasm progression,6,15807404
0,22.1,White blood cell count decreased,3,15807409
1,22.1,Dysgeusia,1,15807409
2,22.1,Neutrophil count decreased,3,15807409
0,21.1,Haematuria traumatic,3,15807515
0,21.1,Nephropathy,2,15807553
0,21.1,Child-Pugh-Turcotte score abnormal,6,15807561
1,21.1,Lower respiratory tract infection,6,15807561
2,21.1,Pyrexia,6,15807561
3,21.1,Hot flush,6,15807561
4,21.1,Neoplasm progression,6,15807561
0,21.1,Wheezing,6,15807580
1,21.1,Disease progression,6,15807580
2,21.1,Death,5,15807580
3,21.1,Asthenia,6,15807580
4,21.1,Cough,6,15807580
0,21.1,Disease progression,5,15807638
0,21.1,Arthralgia,6,15807641
1,21.1,Atypical femur fracture,6,15807641
2,21.1,Metastases to soft tissue,6,15807641
0,22.0,Pyrexia,1,15807643
1,22.0,Asthenia,1,15807643
0,21.1,Osteonecrosis of jaw,6,15807647
0,21.1,Palpitations,,15807664
0,21.1,Pain in extremity,3,15807679
1,21.1,Muscular weakness,2,15807679
2,21.1,Dysarthria,6,15807679
3,21.1,Joint swelling,6,15807679
4,21.1,Weight increased,6,15807679
5,21.1,Abdominal pain upper,3,15807679
6,21.1,Disorientation,6,15807679
7,21.1,Peripheral swelling,6,15807679
0,21.1,Death,5,15807691
0,21.1,Alopecia,6,15807759
1,21.1,Neoplasm progression,6,15807759
2,21.1,Vomiting,1,15807759
3,21.1,Cachexia,6,15807759
4,21.1,Abdominal pain,1,15807759
0,21.1,Neoplasm progression,5,15807807
0,21.1,General physical health deterioration,3,15807817
0,21.1,Pulmonary embolism,6,15807823
1,21.1,Adrenal insufficiency,6,15807823
2,21.1,Neoplasm progression,6,15807823
3,21.1,Pneumocystis jirovecii pneumonia,6,15807823
0,21.1,Death,5,15807833
0,21.1,Death,5,15807844
1,21.1,Malignant neoplasm progression,6,15807844
0,21.1,Weight decreased,3,15807868
1,21.1,Diarrhoea,3,15807868
2,21.1,Death,5,15807868
0,22.1,Vaginal haemorrhage,6,15808094
1,22.1,Anaemia,6,15808094
2,22.1,Hypoaesthesia,1,15808094
3,22.1,Neuropathy peripheral,6,15808094
4,22.1,Aspartate aminotransferase increased,6,15808094
5,22.1,Alanine aminotransferase increased,6,15808094
6,22.1,Abdominal pain lower,3,15808094
7,22.1,Sleep terror,3,15808094
8,22.1,Red cell distribution width increased,3,15808094
9,22.1,Vaginal infection,6,15808094
10,22.1,Flatulence,3,15808094
11,22.1,Hyperkeratosis,6,15808094
12,22.1,Constipation,6,15808094
13,22.1,Carbohydrate antigen 125 increased,3,15808094
14,22.1,Product dose omission,6,15808094
15,22.1,Mean cell haemoglobin increased,3,15808094
16,22.1,Gait disturbance,6,15808094
17,22.1,Red blood cell count decreased,6,15808094
18,22.1,Somnolence,3,15808094
19,22.1,Nail disorder,3,15808094
20,22.1,Nervousness,3,15808094
21,22.1,Platelet count decreased,6,15808094
22,22.1,Haematocrit decreased,3,15808094
23,22.1,Monocyte count increased,3,15808094
24,22.1,Blood alkaline phosphatase increased,6,15808094
25,22.1,Haemoglobin decreased,6,15808094
0,21.1,Neuropathy peripheral,6,15808157
0,21.1,Leukopenia,6,15808158
1,21.1,Small intestinal perforation,6,15808158
2,21.1,Neutropenia,6,15808158
3,21.1,Stomatitis,6,15808158
4,21.1,Haematotoxicity,6,15808158
5,21.1,Toxicity to various agents,6,15808158
6,21.1,Proteinuria,6,15808158
7,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,15808158
0,21.1,Drug intolerance,,15808207
1,21.1,Back pain,,15808207
2,21.1,Pain in extremity,,15808207
3,21.1,Muscle atrophy,,15808207
4,21.1,Disability,,15808207
5,21.1,Fatigue,,15808207
6,21.1,Musculoskeletal pain,,15808207
0,21.1,Neoplasm progression,6,15808256
1,21.1,Product use in unapproved indication,6,15808256
0,21.1,Headache,6,15808257
0,22.0,Death,5,15808287
1,22.0,Asphyxia,6,15808287
2,22.0,Fatigue,6,15808287
0,21.1,Urinary tract infection,1,15808290
1,21.1,Conjunctivitis,1,15808290
2,21.1,Weight decreased,3,15808290
3,21.1,Ammonia increased,3,15808290
4,21.1,Death,5,15808290
5,21.1,Stomatitis,1,15808290
0,21.1,Large intestine perforation,2,15808364
0,21.1,Malignant neoplasm progression,6,15808476
1,21.1,Drug resistance,6,15808476
2,21.1,Pneumonia,6,15808476
3,21.1,General physical health deterioration,1,15808476
4,21.1,Metastatic lymphoma,6,15808476
5,21.1,Drug ineffective,6,15808476
0,21.1,Pain,,15808478
1,21.1,Platelet count decreased,,15808478
2,21.1,General physical health deterioration,,15808478
3,21.1,Nausea,,15808478
4,21.1,Vomiting,,15808478
5,21.1,Blood alkaline phosphatase increased,,15808478
6,21.1,Pain in extremity,,15808478
7,21.1,Productive cough,,15808478
8,21.1,Prostatic specific antigen increased,,15808478
9,21.1,Bedridden,,15808478
10,21.1,Decreased appetite,,15808478
0,21.1,Pyrexia,,15808502
1,21.1,General physical condition decreased,,15808502
0,21.1,Malignant neoplasm progression,6,15808508
0,22.1,Drug-induced liver injury,1,15808517
0,21.1,Metastases to skin,5,15808565
1,21.1,Hormone-refractory prostate cancer,6,15808565
0,21.1,Anxiety,6,15808581
1,21.1,Impaired quality of life,6,15808581
2,21.1,Alopecia,2,15808581
3,21.1,Emotional distress,6,15808581
4,21.1,Psychological trauma,6,15808581
5,21.1,Pain,6,15808581
0,22.0,Psychological trauma,6,15808604
1,22.0,Emotional distress,6,15808604
2,22.0,Alopecia,3,15808604
0,22.0,Emotional distress,6,15808609
1,22.0,Psychological trauma,6,15808609
2,22.0,Alopecia,2,15808609
0,22.0,Interstitial lung disease,1,15808611
0,22.1,Impaired quality of life,6,15808627
1,22.1,Alopecia,3,15808627
2,22.1,Pain,6,15808627
3,22.1,Emotional distress,6,15808627
4,22.1,Anxiety,6,15808627
0,21.1,Alopecia,2,15808631
1,21.1,Psychological trauma,6,15808631
0,22.0,Death,5,15808671
1,22.0,Visual impairment,6,15808671
0,21.1,Death,5,15808695
1,21.1,Agitation,3,15808695
2,21.1,Pain,3,15808695
0,22.1,Alopecia,3,15808788
1,22.1,Pain,6,15808788
2,22.1,Anxiety,6,15808788
3,22.1,Psychological trauma,6,15808788
4,22.1,Emotional distress,6,15808788
5,22.1,Impaired quality of life,6,15808788
0,21.1,Abdominal pain,3,15808821
1,21.1,Fungal skin infection,3,15808821
2,21.1,Oral fungal infection,3,15808821
3,21.1,Large intestine perforation,3,15808821
0,21.1,Malaise,5,15808842
1,21.1,Hypersensitivity,5,15808842
2,21.1,Anaphylactic reaction,5,15808842
3,21.1,Loss of consciousness,5,15808842
4,21.1,Ventricular fibrillation,5,15808842
0,21.1,Tachycardia,1,15808851
1,21.1,Cough,1,15808851
2,21.1,Haematuria,1,15808851
3,21.1,Platelet count decreased,1,15808851
4,21.1,Neutropenia,1,15808851
5,21.1,Parainfluenzae virus infection,1,15808851
6,21.1,Anaemia,1,15808851
7,21.1,Hypotension,1,15808851
8,21.1,Pyrexia,1,15808851
0,21.1,Renal impairment,2,15808873
1,21.1,Pleural effusion,6,15808873
2,21.1,Urine output decreased,6,15808873
0,21.1,Cardiomyopathy,2,15808925
1,21.1,Dry eye,3,15808925
2,21.1,Nausea,1,15808925
3,21.1,Atrial fibrillation,2,15808925
4,21.1,Ventricular extrasystoles,3,15808925
0,22.0,Malignant neoplasm progression,6,15808926
0,21.1,Drug interaction,6,15808942
1,21.1,Dizziness,1,15808942
2,21.1,Hypertension,2,15808942
3,21.1,Fatigue,1,15808942
4,21.1,Asthenia,2,15808942
0,21.1,Retinal vascular disorder,6,15808969
1,21.1,Neutrophil count decreased,6,15808969
2,21.1,Cataract,6,15808969
3,21.1,Retinal vein occlusion,6,15808969
4,21.1,Lacrimation increased,1,15808969
0,21.1,Osteonecrosis of jaw,6,15808979
0,21.1,Pain in jaw,1,15809045
1,21.1,Exostosis of jaw,1,15809045
2,21.1,Osteonecrosis of jaw,1,15809045
3,21.1,Sequestrectomy,1,15809045
4,21.1,Exposed bone in jaw,1,15809045
5,21.1,Oral cavity fistula,1,15809045
0,21.1,Malignant neoplasm progression,6,15809047
1,21.1,Stomatitis,2,15809047
2,21.1,Epistaxis,2,15809047
3,21.1,Blepharitis,2,15809047
4,21.1,Blood pressure increased,2,15809047
5,21.1,Rash,2,15809047
6,21.1,Ovarian cancer,6,15809047
7,21.1,Product use in unapproved indication,6,15809047
0,21.1,Dyspnoea,1,15809115
1,21.1,Asthenia,1,15809115
2,21.1,Cardiac tamponade,1,15809115
3,21.1,Thrombosis,1,15809115
0,21.1,Malaise,2,15809121
1,21.1,Flushing,2,15809121
0,21.1,Malignant neoplasm progression,5,15809122
1,21.1,Glomerular filtration rate decreased,6,15809122
2,21.1,Aspartate aminotransferase increased,6,15809122
3,21.1,Drug ineffective,6,15809122
4,21.1,Red blood cell count decreased,6,15809122
5,21.1,Platelet count decreased,6,15809122
6,21.1,Breast cancer,5,15809122
7,21.1,Alanine aminotransferase increased,6,15809122
0,21.1,Decreased appetite,6,15809128
1,21.1,Metastases to bone,6,15809128
2,21.1,Herpes oesophagitis,6,15809128
3,21.1,Dyspnoea,6,15809128
4,21.1,Peripheral swelling,2,15809128
5,21.1,Constipation,6,15809128
6,21.1,Chest pain,6,15809128
7,21.1,Nephrolithiasis,6,15809128
8,21.1,Epistaxis,6,15809128
9,21.1,Oral mucosal blistering,6,15809128
10,21.1,Pain in extremity,2,15809128
11,21.1,Diarrhoea,6,15809128
12,21.1,Clostridium difficile colitis,1,15809128
0,21.1,Malaise,6,15809213
1,21.1,Product dose omission,6,15809213
2,21.1,Chest pain,1,15809213
0,22.0,Delirium,3,15809235
1,22.0,Hyponatraemia,2,15809235
2,22.0,Sepsis,5,15809235
3,22.0,Plasma cell myeloma,5,15809235
4,22.0,Condition aggravated,3,15809235
5,22.0,Altered state of consciousness,3,15809235
0,21.1,Diarrhoea,2,15809276
1,21.1,Blood creatinine increased,2,15809276
2,21.1,Coma,6,15809276
3,21.1,Epilepsy,6,15809276
4,21.1,Blood alkaline phosphatase increased,6,15809276
5,21.1,Metastases to liver,5,15809276
6,21.1,Urinary tract disorder,2,15809276
7,21.1,Hepatic lesion,5,15809276
8,21.1,Posterior reversible encephalopathy syndrome,5,15809276
9,21.1,Renal disorder,2,15809276
0,21.1,Arteriospasm coronary,1,15809301
0,21.1,Gastrointestinal disorder,6,15809319
0,22.0,Blood count abnormal,6,15809407
1,22.0,Neutrophil count decreased,6,15809407
2,22.0,Motor dysfunction,6,15809407
3,22.0,Cerebrovascular accident,4,15809407
0,21.1,Bacteraemia,2,15809424
1,21.1,Helicobacter infection,2,15809424
2,21.1,Nosocomial infection,2,15809424
0,21.1,Malignant neoplasm progression,5,15809507
1,21.1,Hyperkalaemia,6,15809507
2,21.1,Hypoglycaemia,1,15809507
0,21.1,Memory impairment,6,15809567
0,21.1,Eosinophilic pneumonia chronic,1,15809595
0,21.1,No adverse event,6,15809850
1,21.1,Off label use,6,15809850
2,21.1,Intentional product use issue,6,15809850
0,21.1,Gastrointestinal disorder,6,15810023
1,21.1,Fatigue,6,15810023
0,21.1,Inflammation,3,15810146
1,21.1,Fatigue,6,15810146
2,21.1,Chest pain,1,15810146
3,21.1,Dyspnoea,6,15810146
4,21.1,Cognitive disorder,6,15810146
5,21.1,Skin odour abnormal,6,15810146
0,21.1,Hypophysitis,3,15810288
0,21.1,Flatulence,3,15810397
1,21.1,Product use in unapproved indication,6,15810397
2,21.1,Pain,3,15810397
3,21.1,Abdominal distension,6,15810397
4,21.1,Pneumonia,6,15810397
5,21.1,Atrial fibrillation,6,15810397
6,21.1,Pain in extremity,3,15810397
7,21.1,Insomnia,6,15810397
0,22.0,Death,5,15810514
1,22.0,Product use in unapproved indication,6,15810514
0,21.1,Thrombosis,1,15810656
0,21.1,Pneumonia,6,15810698
0,21.1,Bone pain,2,15810718
0,21.1,Urinary tract infection,5,15810768
1,21.1,Cardiac failure congestive,5,15810768
0,21.1,Abdominal pain,2,15810787
1,21.1,Haemorrhage,1,15810787
2,21.1,Nephrolithiasis,6,15810787
3,21.1,Pelvic pain,2,15810787
4,21.1,Rash,1,15810787
5,21.1,Drug intolerance,6,15810787
6,21.1,Contusion,1,15810787
7,21.1,Tremor,6,15810787
8,21.1,Condition aggravated,6,15810787
9,21.1,Peripheral swelling,6,15810787
10,21.1,Pancytopenia,6,15810787
11,21.1,Malignant neoplasm progression,6,15810787
12,21.1,Drug ineffective,6,15810787
0,21.1,Hot flush,3,15810887
0,21.1,Treatment noncompliance,6,15810895
1,21.1,Death,5,15810895
0,21.1,Death,5,15810900
0,21.1,Death,5,15810985
0,21.1,Thrombocytopenia,1,15811007
1,21.1,Anaemia,3,15811007
2,21.1,Thrombocytopenia,1,15811007
0,21.1,Diabetic metabolic decompensation,1,15811081
0,21.1,Constipation,6,15811098
1,21.1,Diarrhoea,6,15811098
2,21.1,Asthenia,6,15811098
3,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,15811098
4,21.1,Neuropathy peripheral,6,15811098
5,21.1,Bone marrow failure,6,15811098
0,21.1,Skin infection,5,15811112
0,21.1,Renal failure,1,15811236
1,21.1,Haemorrhage urinary tract,1,15811236
2,21.1,Haematuria,1,15811236
3,21.1,Anaemia,6,15811236
4,21.1,Obstruction,1,15811236
0,21.1,Malignant neoplasm progression,3,15811243
0,21.1,Rash,6,15811247
0,21.1,Death,5,15811280
0,21.1,Malignant neoplasm progression,6,15811283
0,21.1,Basal cell carcinoma,6,15811292
0,21.1,Hepatotoxicity,6,15811359
1,21.1,Bone marrow failure,6,15811359
0,21.1,Product dose omission,6,15811378
1,21.1,Stoma site pain,1,15811378
0,21.1,Respiratory failure,5,15811393
0,21.1,Cardiac failure,5,15811415
0,22.1,Dehydration,6,15811435
0,22.0,Hypertension,6,15811453
1,22.0,Renal disorder,6,15811453
0,21.1,Dyspnoea,5,15811479
1,21.1,Colitis ischaemic,5,15811479
2,21.1,Sudden death,5,15811479
0,21.1,Death,5,15811489
1,21.1,Hormone-refractory prostate cancer,6,15811489
2,21.1,Skin cancer metastatic,6,15811489
0,22.0,Fluid retention,1,15811497
1,22.0,White blood cell count decreased,6,15811497
2,22.0,Loss of personal independence in daily activities,2,15811497
3,22.0,Dysstasia,3,15811497
4,22.0,Asthenia,3,15811497
5,22.0,Pain,6,15811497
6,22.0,Joint range of motion decreased,6,15811497
7,22.0,Upper limb fracture,1,15811497
8,22.0,Gait disturbance,3,15811497
9,22.0,Urinary tract infection,1,15811497
10,22.0,Somnolence,3,15811497
11,22.0,Amnesia,3,15811497
12,22.0,Large intestine infection,6,15811497
13,22.0,Oedema,1,15811497
14,22.0,Red blood cell count decreased,6,15811497
15,22.0,Atrophy,3,15811497
16,22.0,Cerebrovascular accident,6,15811497
17,22.0,Clostridium difficile infection,1,15811497
0,22.0,Hair texture abnormal,3,15811499
1,22.0,Alopecia,3,15811499
2,22.0,Hair disorder,3,15811499
3,22.0,Depression,6,15811499
4,22.0,Hair colour changes,3,15811499
5,22.0,Madarosis,3,15811499
0,21.1,Alopecia,3,15811504
0,21.1,Hair disorder,3,15811513
1,21.1,Alopecia,3,15811513
2,21.1,Hair texture abnormal,3,15811513
3,21.1,Hair colour changes,3,15811513
4,21.1,Madarosis,3,15811513
0,21.1,Hair colour changes,6,15811514
1,21.1,Hair texture abnormal,6,15811514
2,21.1,Madarosis,3,15811514
3,21.1,Hair disorder,6,15811514
4,21.1,Alopecia,3,15811514
0,22.0,Accident,6,15811550
0,21.1,Weight increased,6,15811622
0,21.1,Back pain,,15811766
1,21.1,Hot flush,,15811766
0,21.1,Skin hypertrophy,6,15811776
1,21.1,Erythema,6,15811776
2,21.1,Breast disorder,6,15811776
3,21.1,Wound haemorrhage,6,15811776
4,21.1,Peau d^orange,6,15811776
5,21.1,Petechiae,6,15811776
6,21.1,Disease progression,6,15811776
0,21.1,Dermatitis allergic,6,15811779
1,21.1,Tracheobronchitis,6,15811779
2,21.1,Allergic reaction to excipient,6,15811779
3,21.1,Disease progression,6,15811779
4,21.1,Drug ineffective,6,15811779
5,21.1,Immune-mediated adverse reaction,6,15811779
6,21.1,Dyspnoea,6,15811779
0,22.0,Hypersensitivity,6,15811788
1,22.0,Anaphylactic reaction,6,15811788
2,22.0,Generalised erythema,6,15811788
3,22.0,Drug hypersensitivity,6,15811788
0,21.1,Cerebellar infarction,5,15811834
1,21.1,Brain stem syndrome,5,15811834
2,21.1,Interstitial lung disease,5,15811834
3,21.1,Respiratory failure,5,15811834
4,21.1,Cerebral infarction,5,15811834
0,21.1,Toxicity to various agents,6,15811847
1,21.1,Polyneuropathy,1,15811847
0,21.1,Mucosal inflammation,6,15811864
1,21.1,Bone pain,6,15811864
2,21.1,Fatigue,6,15811864
3,21.1,Decreased appetite,6,15811864
4,21.1,Abdominal discomfort,3,15811864
5,21.1,Dyspnoea,6,15811864
6,21.1,Nausea,6,15811864
7,21.1,Hypotension,6,15811864
8,21.1,Fluid intake reduced,6,15811864
9,21.1,Weight decreased,6,15811864
10,21.1,Mobility decreased,6,15811864
11,21.1,Tachycardia,6,15811864
12,21.1,Mental disorder,6,15811864
13,21.1,Dysgeusia,6,15811864
14,21.1,Cardiovascular disorder,6,15811864
15,21.1,Asthenia,6,15811864
0,21.1,Hepatic enzyme increased,1,15811890
0,21.1,Platelet count decreased,2,15811893
0,21.1,Mastitis,1,15811908
0,21.1,Musculoskeletal pain,6,15811909
1,21.1,Weight decreased,6,15811909
2,21.1,Pneumothorax,2,15811909
3,21.1,Nausea,6,15811909
4,21.1,Malignant neoplasm progression,6,15811909
5,21.1,Decreased appetite,6,15811909
0,22.0,Confusional state,6,15811988
1,22.0,Weight decreased,6,15811988
2,22.0,Tongue discomfort,6,15811988
3,22.0,Dry mouth,6,15811988
4,22.0,Renal cancer,6,15811988
5,22.0,Feeding disorder,6,15811988
6,22.0,Malignant neoplasm progression,6,15811988
0,21.1,Malignant neoplasm progression,6,15812012
0,21.1,Transfusion,6,15812045
1,21.1,Product use in unapproved indication,6,15812045
2,21.1,Death,5,15812045
0,21.1,Death,5,15812089
0,21.1,Prostatic disorder,6,15812120
0,21.1,Dysgeusia,,15812121
0,21.1,Focal dyscognitive seizures,3,15812131
1,21.1,Product use issue,6,15812131
0,21.1,Liver disorder,2,15812133
0,21.1,Death,5,15812142
0,21.1,Influenza like illness,,15812166
1,21.1,Urinary tract infection,,15812166
0,21.1,Haematotoxicity,6,15812270
1,21.1,Superior vena cava syndrome,6,15812270
2,21.1,Metastases to bone,6,15812270
0,21.1,Diarrhoea,,15812282
1,21.1,Therapy cessation,,15812282
0,21.1,Hospice care,,15812295
0,21.1,Oliguria,3,15812324
1,21.1,Decreased appetite,3,15812324
0,21.1,Enterocolitis,1,15812362
0,21.1,Death,,15812366
0,22.0,Dyspnoea exertional,3,15812369
1,22.0,Neutropenia,1,15812369
2,22.0,Fatigue,3,15812369
3,22.0,Feeling cold,1,15812369
4,22.0,Neutropenia,1,15812369
5,22.0,Nausea,1,15812369
6,22.0,Neutropenia,3,15812369
7,22.0,Blood creatinine increased,3,15812369
0,22.0,Cholangitis sclerosing,3,15812461
0,21.1,White blood cell count decreased,2,15812562
1,21.1,Red blood cell count decreased,3,15812562
0,21.1,Alopecia,3,15812575
1,21.1,Madarosis,3,15812575
0,21.1,Disease progression,,15812647
0,22.1,Hair texture abnormal,3,15812651
1,22.1,Hair colour changes,3,15812651
2,22.1,Hair disorder,3,15812651
3,22.1,Madarosis,3,15812651
4,22.1,Alopecia,3,15812651
0,21.1,Pyrexia,1,15812707
1,21.1,Disseminated tuberculosis,1,15812707
2,21.1,Dyspnoea,1,15812707
0,21.1,Product use in unapproved indication,6,15812732
1,21.1,Malignant neoplasm progression,6,15812732
0,21.1,Haemoptysis,6,15812735
0,21.1,Renal colic,3,15812819
1,21.1,Urinary retention,3,15812819
0,21.1,Interstitial lung disease,6,15812849
0,21.1,Disease progression,3,15812897
1,21.1,Asthenia,1,15812897
2,21.1,Decreased appetite,1,15812897
0,21.1,Malignant neoplasm progression,6,15812923
1,21.1,Metastases to central nervous system,6,15812923
0,22.0,Death,5,15812927
1,22.0,Product use in unapproved indication,6,15812927
0,21.1,Pain,3,15813074
0,22.0,Musculoskeletal chest pain,6,15813078
1,22.0,"Hallucination, visual",3,15813078
2,22.0,Headache,6,15813078
0,21.1,Disease progression,6,15813092
1,21.1,White blood cell count decreased,6,15813092
2,21.1,Death,5,15813092
3,21.1,General physical health deterioration,6,15813092
0,21.1,Pain,6,15813132
1,21.1,Anxiety,6,15813132
2,21.1,Alopecia,2,15813132
3,21.1,Emotional distress,6,15813132
4,21.1,Impaired quality of life,6,15813132
0,21.1,Fatigue,,15813218
1,21.1,Dry skin,,15813218
2,21.1,Balance disorder,,15813218
3,21.1,Myalgia,,15813218
4,21.1,Nausea,,15813218
5,21.1,Abdominal pain,,15813218
6,21.1,Arthralgia,,15813218
0,21.1,Neutrophil count decreased,,15813248
1,21.1,Therapy cessation,,15813248
0,21.1,Radiotherapy,6,15813270
0,22.1,Panic attack,1,15813276
1,22.1,Pneumothorax,1,15813276
2,22.1,Non-small cell lung cancer,5,15813276
3,22.1,Chronic obstructive pulmonary disease,1,15813276
0,21.1,Neoplasm progression,5,15813285
0,22.0,Pleural effusion,1,15813324
1,22.0,Intentional product use issue,6,15813324
0,21.1,Renal cyst,6,15813336
1,21.1,Aspartate aminotransferase increased,6,15813336
2,21.1,Malignant neoplasm progression,6,15813336
3,21.1,Metastases to lymph nodes,6,15813336
4,21.1,Metastases to liver,6,15813336
5,21.1,White blood cell count decreased,6,15813336
6,21.1,Red blood cell count decreased,6,15813336
7,21.1,Platelet count decreased,6,15813336
8,21.1,Alanine aminotransferase increased,6,15813336
9,21.1,Metastases to lung,6,15813336
0,21.1,Rash,,15813367
0,21.1,Death,,15813391
0,21.1,Hilar lymphadenopathy,,15813396
1,21.1,Prostate cancer,,15813396
2,21.1,Blood alkaline phosphatase increased,,15813396
3,21.1,Prostatic specific antigen increased,,15813396
4,21.1,Pain,,15813396
5,21.1,Metastases to spine,,15813396
6,21.1,Pulmonary mass,,15813396
7,21.1,Back pain,,15813396
0,21.1,Overdose,1,15813404
1,21.1,Miosis,1,15813404
2,21.1,Somnolence,1,15813404
0,21.1,Small intestinal obstruction,1,15813406
0,21.1,Exostosis of jaw,1,15813421
1,21.1,Pain in jaw,1,15813421
2,21.1,Oral cavity fistula,1,15813421
3,21.1,Exposed bone in jaw,1,15813421
4,21.1,Osteonecrosis of jaw,1,15813421
5,21.1,Sequestrectomy,1,15813421
0,21.1,Dyspnoea,2,15813438
1,21.1,Loss of consciousness,2,15813438
2,21.1,Hypersensitivity,2,15813438
3,21.1,Erythema,2,15813438
4,21.1,Hypotension,2,15813438
0,21.1,Anaemia,,15813460
1,21.1,Back pain,,15813460
2,21.1,Bone pain,,15813460
3,21.1,Metastases to bone,,15813460
4,21.1,Arthralgia,,15813460
5,21.1,Bone disorder,,15813460
6,21.1,Pain,,15813460
0,21.1,Weight decreased,,15813467
1,21.1,Hypophagia,,15813467
2,21.1,Decreased appetite,,15813467
3,21.1,Prostatic specific antigen increased,,15813467
4,21.1,Metastases to bone,,15813467
5,21.1,Haematochezia,,15813467
0,22.0,Nervousness,6,15813485
1,22.0,Taste disorder,6,15813485
2,22.0,Fatigue,3,15813485
3,22.0,Neoplasm progression,6,15813485
4,22.0,Nausea,3,15813485
5,22.0,Leukopenia,6,15813485
6,22.0,Decreased appetite,6,15813485
7,22.0,Headache,1,15813485
0,22.1,Madarosis,3,15813493
1,22.1,Alopecia,3,15813493
2,22.1,Hair texture abnormal,3,15813493
3,22.1,Hair disorder,3,15813493
4,22.1,Hair colour changes,3,15813493
0,22.0,Thrombocytopenia,6,15813497
1,22.0,Leukopenia,6,15813497
0,21.1,Malignant neoplasm progression,6,15813506
1,21.1,Death,5,15813506
2,21.1,Therapeutic response changed,6,15813506
0,21.1,Non-small cell lung cancer metastatic,6,15813535
1,21.1,Unevaluable event,6,15813535
0,21.1,Myalgia,,15813548
1,21.1,Pelvic venous thrombosis,,15813548
2,21.1,Pain of skin,,15813548
3,21.1,Ascites,,15813548
4,21.1,Alopecia,,15813548
5,21.1,Abdominal pain upper,,15813548
6,21.1,Weight decreased,,15813548
7,21.1,Lymphadenopathy,,15813548
8,21.1,Diarrhoea,,15813548
9,21.1,Muscle spasms,,15813548
10,21.1,Asthenia,,15813548
11,21.1,Skin fragility,,15813548
12,21.1,Sciatica,,15813548
13,21.1,Abdominal pain upper,,15813548
14,21.1,Metastases to lung,,15813548
15,21.1,Arthralgia,,15813548
16,21.1,Decreased appetite,,15813548
17,21.1,Epigastric discomfort,,15813548
18,21.1,Dry skin,,15813548
19,21.1,Aphthous ulcer,,15813548
20,21.1,Skin erosion,,15813548
21,21.1,Lymphadenopathy,,15813548
0,21.1,Unevaluable event,6,15813555
1,21.1,Non-small cell lung cancer metastatic,6,15813555
0,21.1,Gastrointestinal disorder,6,15813578
1,21.1,Non-small cell lung cancer metastatic,6,15813578
0,21.1,Death,5,15813581
1,21.1,Malaise,1,15813581
2,21.1,Hypotension,6,15813581
0,21.1,Pulmonary thrombosis,6,15813584
0,21.1,Hospice care,,15813586
0,21.1,Prostate cancer metastatic,5,15813587
0,21.1,Haemoglobin increased,6,15813618
1,21.1,Tumour marker increased,6,15813618
0,21.1,Hepatic failure,5,15813642
1,21.1,Malignant transformation,5,15813642
2,21.1,Drug resistance,5,15813642
0,21.1,Therapy cessation,,15813655
1,21.1,Surgery,,15813655
0,21.1,Death,5,15813675
0,21.1,Hospitalisation,,15813716
0,21.1,Adverse event,,15813735
0,21.1,Death,,15813738
0,21.1,Proteinuria,6,15813800
1,21.1,Blood creatinine increased,6,15813800
2,21.1,Spleen disorder,6,15813800
3,21.1,Blood urea increased,6,15813800
0,21.1,Pain of skin,3,15813814
1,21.1,Trigger finger,3,15813814
2,21.1,Groin pain,3,15813814
3,21.1,Burning sensation,3,15813814
0,21.1,Therapy cessation,,15813820
1,21.1,Abdominal pain,6,15813820
2,21.1,Disease progression,5,15813820
3,21.1,Laboratory test abnormal,3,15813820
4,21.1,Off label use,,15813820
0,21.1,Palmar-plantar erythrodysaesthesia syndrome,2,15813825
0,21.1,Pneumocystis jirovecii pneumonia,3,15813828
0,21.1,Mucosal inflammation,5,15813829
1,21.1,Drug interaction,5,15813829
2,21.1,Bone marrow failure,5,15813829
0,21.1,Respiratory failure,5,15813835
1,21.1,Off label use,6,15813835
0,21.1,Metastases to central nervous system,6,15813913
1,21.1,Off label use,6,15813913
2,21.1,Product use in unapproved indication,6,15813913
0,21.1,Death,5,15813916
1,21.1,Hospitalisation,6,15813916
0,21.1,Pollakiuria,3,15813965
1,21.1,Dysuria,3,15813965
0,21.1,Interstitial lung disease,4,15813990
1,21.1,Cardio-respiratory arrest,5,15813990
2,21.1,Radiation pneumonitis,6,15813990
3,21.1,Pulmonary hypertension,2,15813990
4,21.1,Right ventricular failure,2,15813990
5,21.1,Chronic respiratory failure,6,15813990
0,22.0,Blood pressure fluctuation,1,15814011
1,22.0,Pneumonia bacterial,1,15814011
2,22.0,Septic shock,6,15814011
3,22.0,Bone marrow failure,6,15814011
0,21.1,Non-small cell lung cancer,6,15814243
1,21.1,Malignant neoplasm progression,6,15814243
2,21.1,Pneumonia,5,15814243
3,21.1,Metastases to central nervous system,3,15814243
0,21.1,Metastases to lung,6,15814265
1,21.1,Malignant neoplasm progression,6,15814265
2,21.1,Breast cancer,6,15814265
0,22.1,Laboratory test abnormal,2,15814338
1,22.1,Nausea,3,15814338
2,22.1,Insomnia,3,15814338
3,22.1,Red blood cell count decreased,6,15814338
4,22.1,Subclavian vein stenosis,6,15814338
5,22.1,Hypoxia,3,15814338
6,22.1,Fatigue,3,15814338
7,22.1,Haematocrit decreased,6,15814338
8,22.1,Ventilation perfusion mismatch,6,15814338
9,22.1,Respiratory tract infection,6,15814338
10,22.1,Accidental overdose,6,15814338
11,22.1,Platelet count decreased,1,15814338
12,22.1,Asthenia,6,15814338
13,22.1,Dizziness,2,15814338
14,22.1,Haemoglobin decreased,3,15814338
15,22.1,Heart rate increased,6,15814338
16,22.1,Dyspnoea,3,15814338
17,22.1,Mean cell haemoglobin increased,2,15814338
18,22.1,Respiration abnormal,3,15814338
19,22.1,White blood cell count decreased,6,15814338
20,22.1,Neutrophil count decreased,1,15814338
0,21.1,Metastases to central nervous system,6,15814373
0,21.1,Feeling hot,1,15814402
1,21.1,Back pain,1,15814402
2,21.1,Erythema,1,15814402
0,21.1,White blood cell count decreased,3,15814417
1,21.1,Pyrexia,6,15814417
2,21.1,Nausea,2,15814417
3,21.1,Asthenia,6,15814417
4,21.1,Joint swelling,6,15814417
5,21.1,Diarrhoea,2,15814417
6,21.1,Headache,3,15814417
7,21.1,Arthralgia,6,15814417
8,21.1,Death,5,15814417
9,21.1,Fatigue,3,15814417
10,21.1,Insomnia,6,15814417
11,21.1,Anaemia,6,15814417
0,21.1,Cerebrovascular accident,1,15814463
0,22.1,Pain,3,15814482
1,22.1,Neutrophil count decreased,1,15814482
2,22.1,Anaemia,3,15814482
3,22.1,Diarrhoea,1,15814482
4,22.1,Death,5,15814482
5,22.1,Diarrhoea,3,15814482
6,22.1,Neutrophil count decreased,1,15814482
7,22.1,Neutrophil count decreased,1,15814482
8,22.1,Diarrhoea,1,15814482
9,22.1,Peripheral sensory neuropathy,1,15814482
10,22.1,Stomatitis,1,15814482
0,21.1,Constipation,6,15814497
1,21.1,Fatigue,6,15814497
2,21.1,Decreased appetite,2,15814497
3,21.1,Haemoglobin abnormal,6,15814497
4,21.1,Appendix disorder,6,15814497
5,21.1,Poor quality sleep,6,15814497
6,21.1,Dysgeusia,2,15814497
7,21.1,Breast cancer female,6,15814497
8,21.1,Malignant neoplasm progression,6,15814497
9,21.1,Visual impairment,6,15814497
0,21.1,Second primary malignancy,6,15814537
1,21.1,Acute myeloid leukaemia,6,15814537
0,21.1,Exostosis of jaw,1,15814610
1,21.1,Pain in jaw,1,15814610
2,21.1,Osteonecrosis of jaw,1,15814610
3,21.1,Oral cavity fistula,1,15814610
4,21.1,Exposed bone in jaw,1,15814610
0,22.0,Urinary tract infection,5,15814611
0,21.1,Urinary tract infection,1,15814629
0,22.1,Herpes virus infection,6,15814734
1,22.1,Breast discharge,6,15814734
0,21.1,Diarrhoea,3,15814744
0,21.1,Drug hypersensitivity,6,15814748
1,21.1,Confusional state,6,15814748
2,21.1,Influenza,6,15814748
0,22.0,Neutropenia,1,15814835
1,22.0,Nausea,1,15814835
2,22.0,Cough,1,15814835
3,22.0,Alanine aminotransferase increased,6,15814835
4,22.0,Fatigue,3,15814835
5,22.0,Rash,3,15814835
6,22.0,Hepatic failure,4,15814835
7,22.0,Rash maculo-papular,1,15814835
8,22.0,Aspartate aminotransferase increased,6,15814835
9,22.0,Gamma-glutamyltransferase increased,6,15814835
10,22.0,Peripheral sensory neuropathy,3,15814835
0,21.1,Urinary retention,2,15814836
1,21.1,Thrombosis,2,15814836
0,21.1,Neutrophil count decreased,6,15814838
1,21.1,Enterocolitis infectious,1,15814838
2,21.1,Anaemia,1,15814838
3,21.1,Off label use,6,15814838
4,21.1,Platelet count decreased,3,15814838
5,21.1,Mucosal inflammation,6,15814838
6,21.1,Weight decreased,3,15814838
0,21.1,Off label use,6,15814842
1,21.1,General physical health deterioration,2,15814842
2,21.1,Metastases to liver,6,15814842
3,21.1,Blood lactate dehydrogenase increased,6,15814842
4,21.1,Pain,6,15814842
5,21.1,Tumour marker increased,6,15814842
0,21.1,Hypomagnesaemia,1,15814850
0,21.1,Proctalgia,1,15814856
1,21.1,Pelvic abscess,1,15814856
2,21.1,Perianal erythema,1,15814856
3,21.1,Fatigue,1,15814856
0,21.1,Intestinal perforation,5,15814858
0,21.1,Oedema peripheral,1,15814865
1,21.1,C-reactive protein increased,1,15814865
2,21.1,Anaemia of malignant disease,1,15814865
3,21.1,Tachycardia,1,15814865
4,21.1,Depression,1,15814865
5,21.1,Hyperventilation,1,15814865
6,21.1,Pyrexia,1,15814865
7,21.1,Hepatic pain,1,15814865
8,21.1,Death,5,15814865
9,21.1,Diverticulitis,1,15814865
10,21.1,Pneumonia,4,15814865
0,21.1,Fournier^s gangrene,1,15814869
1,21.1,Ascites,1,15814869
2,21.1,Renal impairment,1,15814869
3,21.1,Diarrhoea,1,15814869
0,21.1,Abdominal pain,1,15814888
1,21.1,Vomiting,1,15814888
2,21.1,Nausea,1,15814888
3,21.1,Decreased appetite,1,15814888
4,21.1,Off label use,6,15814888
0,21.1,Cardiac arrest,5,15814891
1,21.1,Hypoxia,5,15814891
2,21.1,Coma,5,15814891
0,21.1,Agranulocytosis,1,15814895
0,21.1,Visual acuity reduced,3,15814901
1,21.1,Papilloedema,3,15814901
0,21.1,Anaemia,1,15814912
1,21.1,Thrombocytopenia,1,15814912
2,21.1,Haemoptysis,1,15814912
3,21.1,Epistaxis,1,15814912
0,21.1,Type I hypersensitivity,1,15814913
0,21.1,Hyperhidrosis,1,15814937
1,21.1,Abdominal pain upper,1,15814937
2,21.1,Tachycardia,1,15814937
3,21.1,Hypertension,1,15814937
0,21.1,Burning sensation,1,15814939
1,21.1,Infusion related reaction,1,15814939
2,21.1,Paraesthesia,1,15814939
0,21.1,Diabetic hyperosmolar coma,3,15814941
0,21.1,Enteritis,2,15814943
0,21.1,Angioedema,1,15814944
1,21.1,Back pain,1,15814944
2,21.1,Hypersensitivity,1,15814944
3,21.1,Peripheral sensory neuropathy,3,15814944
4,21.1,Folliculitis,1,15814944
5,21.1,Mucosal inflammation,3,15814944
0,21.1,Hypotension,3,15814945
1,21.1,Off label use,6,15814945
2,21.1,Rash pruritic,1,15814945
3,21.1,Pyrexia,1,15814945
4,21.1,Eosinophilia,3,15814945
0,21.1,Malaise,1,15814948
1,21.1,Pruritus,1,15814948
2,21.1,Abdominal pain,1,15814948
3,21.1,Erythema,1,15814948
4,21.1,Dyspnoea,1,15814948
5,21.1,Hyperhidrosis,1,15814948
6,21.1,Hypersensitivity,1,15814948
7,21.1,Hypotension,1,15814948
0,21.1,Metrorrhagia,1,15815069
1,21.1,Endometrial disorder,1,15815069
0,21.1,Intestinal ischaemia,6,15815106
1,21.1,Cognitive disorder,3,15815106
2,21.1,Stress,3,15815106
3,21.1,Arthritis,3,15815106
0,22.0,Weight decreased,6,15815121
1,22.0,Pruritus,6,15815121
2,22.0,Rash,6,15815121
3,22.0,Urticaria,6,15815121
4,22.0,Memory impairment,1,15815121
5,22.0,Taste disorder,6,15815121
6,22.0,Malaise,1,15815121
7,22.0,Fatigue,6,15815121
8,22.0,Platelet count decreased,6,15815121
0,21.1,Treatment noncompliance,6,15815149
1,21.1,Thoracic vertebral fracture,2,15815149
0,22.0,Metastases to liver,6,15815151
1,22.0,Chronic hepatic failure,6,15815151
2,22.0,Hepatic cirrhosis,5,15815151
3,22.0,Liver disorder,5,15815151
4,22.0,Malignant neoplasm progression,6,15815151
5,22.0,Peritoneal disorder,6,15815151
6,22.0,Metastases to bone,6,15815151
7,22.0,Hepatic function abnormal,5,15815151
0,21.1,Temporal arteritis,3,15815159
1,21.1,Blindness,3,15815159
0,21.1,Rash,1,15815195
1,21.1,Pruritus,1,15815195
2,21.1,Abdominal pain upper,1,15815195
0,21.1,Anal incontinence,2,15815212
1,21.1,Loss of consciousness,2,15815212
2,21.1,Off label use,6,15815212
3,21.1,Erythema,2,15815212
4,21.1,Presyncope,2,15815212
5,21.1,Vomiting,2,15815212
0,21.1,Headache,2,15815221
1,21.1,Urticaria,2,15815221
2,21.1,Vision blurred,2,15815221
3,21.1,Neutropenic sepsis,2,15815221
4,21.1,Body temperature increased,2,15815221
0,21.1,Haemolytic anaemia,2,15815229
0,21.1,Muscular weakness,1,15815231
1,21.1,Hypotension,1,15815231
2,21.1,Product substitution issue,1,15815231
3,21.1,Malaise,1,15815231
0,21.1,Diplopia,3,15815233
1,21.1,Balance disorder,3,15815233
2,21.1,Tremor,3,15815233
3,21.1,Dysphagia,3,15815233
4,21.1,Fall,6,15815233
0,21.1,Sleep disorder,3,15815234
1,21.1,Joint stiffness,3,15815234
2,21.1,Hyperhidrosis,3,15815234
3,21.1,Weight increased,3,15815234
4,21.1,Pain,3,15815234
0,21.1,Retching,1,15815299
1,21.1,Hypoxia,1,15815299
2,21.1,Nausea,1,15815299
3,21.1,Flushing,1,15815299
4,21.1,Back pain,1,15815299
5,21.1,Hyperhidrosis,1,15815299
0,21.1,Metastases to soft tissue,6,15815329
1,21.1,Drug ineffective,6,15815329
2,21.1,Drug resistance,6,15815329
0,21.1,Anaemia,3,15815339
1,21.1,Hormone-refractory prostate cancer,3,15815339
2,21.1,General physical condition decreased,3,15815339
0,21.1,Ejection fraction decreased,3,15815369
0,21.1,Vomiting,1,15815457
1,21.1,Disease progression,6,15815457
2,21.1,Abdominal pain,1,15815457
3,21.1,Alopecia,6,15815457
4,21.1,Cachexia,6,15815457
0,21.1,Death,5,15815473
0,22.0,Hypersensitivity,6,15815516
1,22.0,Weight increased,6,15815516
2,22.0,Abdominal pain,6,15815516
3,22.0,Nocturnal dyspnoea,6,15815516
4,22.0,Cardiac failure,6,15815516
5,22.0,Diarrhoea,6,15815516
0,21.1,Livedo reticularis,1,15815539
1,21.1,Anaphylactic shock,6,15815539
2,21.1,Chills,1,15815539
3,21.1,Device related infection,6,15815539
4,21.1,Hypersensitivity,6,15815539
5,21.1,Haemoglobin decreased,3,15815539
6,21.1,Red blood cell count decreased,6,15815539
7,21.1,Platelet count decreased,1,15815539
8,21.1,Pyrexia,1,15815539
9,21.1,Malaise,6,15815539
0,21.1,Foot deformity,1,15815565
1,21.1,Polyneuropathy,3,15815565
2,21.1,Leukopenia,1,15815565
3,21.1,Fall,6,15815565
4,21.1,Pleural effusion,3,15815565
5,21.1,Cardiac failure,3,15815565
0,21.1,Urinary tract infection,1,15815566
1,21.1,Vomiting,1,15815566
2,21.1,Pyrexia,1,15815566
3,21.1,Nausea,1,15815566
4,21.1,Diarrhoea,1,15815566
0,21.1,Blood pressure decreased,6,15815570
1,21.1,Shock,1,15815570
0,21.1,Febrile neutropenia,2,15815589
0,21.1,Urticaria,2,15815606
1,21.1,Body temperature increased,2,15815606
2,21.1,Vision blurred,2,15815606
3,21.1,Headache,2,15815606
4,21.1,Neutropenic sepsis,2,15815606
0,21.1,Haemorrhage,6,15815622
1,21.1,Device expulsion,6,15815622
0,21.1,Complication of device insertion,6,15815757
1,21.1,Procedural pain,3,15815757
0,21.1,Complication of device insertion,6,15815788
0,21.1,Device expulsion,1,15816460
1,21.1,Pain,1,15816460
2,21.1,Vaginal haemorrhage,6,15816460
0,21.1,Device expulsion,1,15816964
0,21.1,Confusional state,6,15817653
1,21.1,Disturbance in attention,6,15817653
0,21.1,Cardiac failure congestive,1,15817772
0,21.1,Tachycardia,1,15817777
1,21.1,Abdominal pain,1,15817777
2,21.1,Hot flush,1,15817777
0,21.1,Device dislocation,3,15818469
1,21.1,Muscle spasms,6,15818469
2,21.1,Device expulsion,3,15818469
3,21.1,Haemorrhage,6,15818469
0,21.1,Device dislocation,6,15818472
0,21.1,Device dislocation,1,15818484
0,21.1,Parkinson^s disease,6,15818664
0,21.1,Pain,6,15818665
1,21.1,Cardiac disorder,6,15818665
2,21.1,Movement disorder,6,15818665
0,21.1,Pulmonary haemorrhage,5,15818704
0,21.1,Atrial fibrillation,1,15818716
1,21.1,Acute kidney injury,1,15818716
2,21.1,Pneumonia,1,15818716
3,21.1,Malignant neoplasm progression,6,15818716
0,21.1,Pruritus,6,15818726
0,22.0,Death,5,15818730
0,21.1,Anaphylactic shock,1,15818750
1,21.1,Anaphylactic shock,6,15818750
0,21.1,Encephalitis,1,15818828
1,21.1,Rash,2,15818828
2,21.1,Skin disorder,6,15818828
3,21.1,Colitis,5,15818828
4,21.1,Malignant neoplasm progression,5,15818828
5,21.1,Pneumonia,6,15818828
0,21.1,Nausea,1,15818883
1,21.1,Erythema,1,15818883
2,21.1,Respiratory distress,1,15818883
3,21.1,Blood pressure decreased,1,15818883
4,21.1,Sensory level abnormal,1,15818883
0,21.1,Hypotension,1,15818970
1,21.1,Fatigue,1,15818970
2,21.1,Hypersensitivity,1,15818970
3,21.1,Renal disorder,1,15818970
0,21.1,Clostridium difficile infection,6,15819040
0,21.1,Intentional product use issue,6,15819042
1,21.1,Off label use,6,15819042
2,21.1,No adverse event,6,15819042
0,21.1,Nausea,1,15819052
1,21.1,Vomiting,1,15819052
0,21.1,Soft tissue mass,1,15819101
0,21.1,No adverse event,6,15819133
1,21.1,Off label use,6,15819133
2,21.1,Intentional product use issue,6,15819133
0,21.1,Pneumonitis,2,15819139
0,21.1,Ill-defined disorder,3,15819209
1,21.1,Feeding disorder,3,15819209
2,21.1,Vomiting,3,15819209
3,21.1,Nausea,3,15819209
0,21.1,Injection site pain,1,15819312
1,21.1,Abdominal discomfort,1,15819312
2,21.1,Arthralgia,3,15819312
3,21.1,Nausea,1,15819312
4,21.1,Pain in extremity,1,15819312
5,21.1,Arthropathy,3,15819312
6,21.1,Diarrhoea,1,15819312
7,21.1,Gait disturbance,1,15819312
8,21.1,Bone pain,1,15819312
0,21.1,Full blood count decreased,6,15819347
1,21.1,Blood pressure decreased,6,15819347
2,21.1,Haemoglobin decreased,6,15819347
0,21.1,Lung neoplasm malignant,6,15819350
1,21.1,Dizziness,1,15819350
0,21.1,Bone pain,6,15819352
0,21.1,Inappropriate schedule of product administration,6,15819389
1,21.1,Respiratory disorder,6,15819389
0,21.1,Constipation,3,15819407
1,21.1,Dizziness,3,15819407
2,21.1,Gastrointestinal haemorrhage,5,15819407
3,21.1,Vomiting,3,15819407
0,21.1,Arrhythmia,6,15819426
1,21.1,Loss of consciousness,6,15819426
0,21.1,Pleural effusion,3,15819451
1,21.1,Dyspnoea,3,15819451
0,21.1,Acute hepatic failure,5,15819473
0,21.1,Cardiac arrest,6,15819483
1,21.1,Ascites,6,15819483
2,21.1,Atrial fibrillation,6,15819483
3,21.1,Hypotension,6,15819483
4,21.1,Pneumonia,6,15819483
5,21.1,Pleural effusion,5,15819483
6,21.1,Respiratory failure,6,15819483
0,21.1,No adverse event,6,15819490
0,21.1,Headache,6,15819495
1,21.1,Product use in unapproved indication,6,15819495
2,21.1,Nausea,6,15819495
3,21.1,Dysphagia,6,15819495
4,21.1,Decreased appetite,6,15819495
5,21.1,Burning sensation,6,15819495
6,21.1,Dizziness,6,15819495
7,21.1,Malaise,6,15819495
0,21.1,Clostridium difficile colitis,2,15819566
0,22.0,Weight decreased,1,15819595
1,22.0,Decreased appetite,1,15819595
2,22.0,Fatigue,1,15819595
3,22.0,Hypertension,1,15819595
4,22.0,Musculoskeletal pain,1,15819595
5,22.0,Prostatic specific antigen increased,1,15819595
6,22.0,Hydronephrosis,1,15819595
7,22.0,Haematuria,1,15819595
8,22.0,Asthenia,1,15819595
9,22.0,Headache,1,15819595
10,22.0,Malignant neoplasm progression,2,15819595
0,21.1,Neutropenia,3,15819605
0,21.1,Hidradenitis,1,15819645
0,21.1,Colon cancer,3,15819675
0,21.1,Diarrhoea,1,15819740
0,22.0,Oxygen saturation decreased,6,15819747
1,22.0,Dyspnoea,6,15819747
2,22.0,Headache,6,15819747
3,22.0,Cyanosis,6,15819747
4,22.0,Chest discomfort,6,15819747
5,22.0,Pyrexia,6,15819747
6,22.0,Death,5,15819747
7,22.0,Heart rate increased,6,15819747
8,22.0,Vomiting,6,15819747
0,21.1,Fatigue,6,15819759
1,21.1,Pain in extremity,6,15819759
2,21.1,Weight increased,6,15819759
3,21.1,Blood triglycerides increased,6,15819759
4,21.1,Stomatitis,6,15819759
5,21.1,Dental caries,6,15819759
6,21.1,Dyspnoea,6,15819759
7,21.1,Dysphagia,6,15819759
8,21.1,Blood potassium decreased,6,15819759
0,21.1,Salivary gland cancer,6,15819796
1,21.1,Malignant neoplasm progression,6,15819796
0,21.1,Metastases to liver,5,15819802
1,21.1,Hepatic lesion,5,15819802
2,21.1,Epilepsy,6,15819802
3,21.1,Blood alkaline phosphatase increased,6,15819802
4,21.1,Urinary tract disorder,2,15819802
5,21.1,Blood creatinine increased,2,15819802
6,21.1,Coma,6,15819802
7,21.1,Posterior reversible encephalopathy syndrome,5,15819802
8,21.1,Diarrhoea,2,15819802
9,21.1,Renal disorder,2,15819802
0,21.1,Death,5,15819814
0,21.1,Delirium,6,15819816
1,21.1,Restlessness,6,15819816
2,21.1,Somnolence,6,15819816
3,21.1,Brachial plexopathy,6,15819816
4,21.1,Malaise,2,15819816
0,21.1,Enteritis infectious,5,15819852
0,22.0,Pulmonary embolism,6,15819856
1,22.0,Cardiac failure acute,6,15819856
2,22.0,Pneumonia,6,15819856
3,22.0,Cardiac failure congestive,6,15819856
4,22.0,Neutropenia,6,15819856
5,22.0,Cardiac failure,6,15819856
6,22.0,Infusion related reaction,6,15819856
7,22.0,Ejection fraction decreased,6,15819856
0,22.0,Chest pain,6,15819867
0,21.1,Pharyngitis,1,15819868
0,21.1,Prostate cancer metastatic,6,15819869
1,21.1,Pain,6,15819869
2,21.1,Speech disorder,6,15819869
0,22.0,Urinary retention,1,15819926
1,22.0,Constipation,1,15819926
2,22.0,Nausea,1,15819926
3,22.0,Dizziness,1,15819926
0,21.1,Chills,3,15819949
1,21.1,Pyrexia,3,15819949
2,21.1,Dyspnoea,3,15819949
0,21.1,Liver function test increased,6,15819965
1,21.1,Hepatic enzyme increased,6,15819965
0,21.1,Pyrexia,6,15819996
1,21.1,Lower respiratory tract infection,6,15819996
2,21.1,Hot flush,6,15819996
3,21.1,Neoplasm progression,6,15819996
4,21.1,Child-Pugh-Turcotte score abnormal,6,15819996
0,22.0,Nephropathy,1,15820020
0,21.1,Cardiomyopathy,6,15820088
0,21.1,Slow speech,6,15820135
1,21.1,Product use in unapproved indication,6,15820135
2,21.1,Cognitive disorder,6,15820135
3,21.1,Motor dysfunction,6,15820135
0,21.1,Bone marrow failure,1,15820137
1,21.1,Hepatic function abnormal,1,15820137
0,21.1,Death,5,15820139
0,21.1,Gingivitis,2,15820143
1,21.1,Osteonecrosis of jaw,2,15820143
0,21.1,General physical health deterioration,6,15820193
1,21.1,Blood pressure increased,3,15820193
2,21.1,Weight decreased,6,15820193
3,21.1,Fluid retention,3,15820193
4,21.1,Asthenia,3,15820193
5,21.1,Rhinorrhoea,3,15820193
6,21.1,Diarrhoea,3,15820193
7,21.1,Stomatitis,3,15820193
8,21.1,Decreased appetite,6,15820193
9,21.1,Deep vein thrombosis,6,15820193
10,21.1,Abdominal pain upper,3,15820193
11,21.1,Pneumonia,6,15820193
12,21.1,Fatigue,3,15820193
13,21.1,Myalgia,3,15820193
14,21.1,Arthralgia,3,15820193
0,21.1,Rhabdomyolysis,2,15820200
1,21.1,Drug interaction,2,15820200
0,21.1,Speech disorder,6,15820202
1,21.1,Motor dysfunction,1,15820202
2,21.1,Prostatic specific antigen increased,6,15820202
3,21.1,Cognitive disorder,6,15820202
0,21.1,Motor dysfunction,6,15820213
1,21.1,Cognitive disorder,6,15820213
2,21.1,Slow speech,6,15820213
0,21.1,Polymyalgia rheumatica,1,15820217
1,21.1,Anxiety,6,15820217
2,21.1,Insomnia,6,15820217
0,21.1,Febrile neutropenia,6,15820226
1,21.1,Urinary tract infection,3,15820226
0,21.1,Abdominal pain,3,15820231
1,21.1,Diarrhoea,3,15820231
0,21.1,Breast cancer metastatic,6,15820255
1,21.1,Malignant neoplasm progression,6,15820255
0,21.1,Slow speech,6,15820271
1,21.1,Fall,6,15820271
2,21.1,Cognitive disorder,6,15820271
3,21.1,Motor dysfunction,6,15820271
0,21.1,Chest discomfort,6,15820274
1,21.1,Transient ischaemic attack,6,15820274
0,21.1,Migraine,6,15820295
1,21.1,Sepsis,6,15820295
2,21.1,Intracranial pressure increased,6,15820295
3,21.1,Meningitis,6,15820295
4,21.1,Vomiting,1,15820295
5,21.1,Influenza,6,15820295
6,21.1,Nausea,1,15820295
7,21.1,Muscular weakness,6,15820295
0,22.1,Autoimmune haemolytic anaemia,2,15820323
1,22.1,Aplasia pure red cell,2,15820323
2,22.1,Diarrhoea,3,15820323
0,21.1,Paraesthesia,,15820332
0,21.1,Cardiac disorder,5,15820338
1,21.1,Neoplasm malignant,5,15820338
0,21.1,Death,5,15820339
0,21.1,Death,5,15820342
0,21.1,Aplastic anaemia,3,15820351
1,21.1,Granulocytopenia,6,15820351
2,21.1,Immune thrombocytopenic purpura,3,15820351
0,21.1,Seizure,6,15820360
1,21.1,Urosepsis,6,15820360
0,21.1,Off label use,6,15820370
1,21.1,Dysgeusia,6,15820370
2,21.1,Onychomadesis,6,15820370
3,21.1,White blood cell count decreased,6,15820370
4,21.1,Haematochezia,6,15820370
5,21.1,Discomfort,6,15820370
6,21.1,Intentional product use issue,6,15820370
7,21.1,Appetite disorder,6,15820370
0,21.1,Drug interaction,6,15820377
1,21.1,Skin erosion,6,15820377
2,21.1,Squamous cell carcinoma of skin,1,15820377
3,21.1,Impaired healing,2,15820377
0,21.1,Chemotherapy,6,15820432
0,21.1,Dysphagia,3,15820433
1,21.1,Confusional state,3,15820433
2,21.1,Neoplasm malignant,5,15820433
0,21.1,Hyperventilation,3,15820436
1,21.1,Hypokalaemia,3,15820436
2,21.1,Electrocardiogram QT prolonged,3,15820436
3,21.1,Metabolic alkalosis,3,15820436
4,21.1,Condition aggravated,3,15820436
5,21.1,Tachyarrhythmia,3,15820436
6,21.1,Acute kidney injury,3,15820436
7,21.1,Respiratory failure,3,15820436
8,21.1,Right ventricular failure,3,15820436
9,21.1,Drug resistance,3,15820436
0,21.1,Infusion related reaction,1,15820478
1,21.1,Stress cardiomyopathy,1,15820478
0,21.1,Oesophageal stenosis,,15820522
1,21.1,Eating disorder,,15820522
2,21.1,Pain in extremity,,15820522
